These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 17168239

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
    Waragai M, Moriya M, Nojo T.
    J Alzheimers Dis; 2017; 60(4):1411-1427. PubMed ID: 28968236
    [Abstract] [Full Text] [Related]

  • 23. Multimodal imaging in diagnosis of Alzheimer's disease and amnestic mild cognitive impairment: value of magnetic resonance spectroscopy, perfusion, and diffusion tensor imaging of the posterior cingulate region.
    Zimny A, Szewczyk P, Trypka E, Wojtynska R, Noga L, Leszek J, Sasiadek M.
    J Alzheimers Dis; 2011; 27(3):591-601. PubMed ID: 21841260
    [Abstract] [Full Text] [Related]

  • 24. A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI.
    Jessen F, Gür O, Block W, Ende G, Frölich L, Hammen T, Wiltfang J, Kucinski T, Jahn H, Heun R, Maier W, Kölsch H, Kornhuber J, Träber F.
    Neurology; 2009 May 19; 72(20):1735-40. PubMed ID: 19451528
    [Abstract] [Full Text] [Related]

  • 25. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
    Bittner DM, Heinze HJ, Kaufmann J.
    J Alzheimers Dis; 2013 May 19; 36(1):155-63. PubMed ID: 23579327
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. MRS in mild cognitive impairment: early differentiation of dementia with Lewy bodies and Alzheimer's disease.
    Zhang B, Ferman TJ, Boeve BF, Smith GE, Maroney-Smith M, Spychalla AJ, Knopman DS, Jack CR, Petersen RC, Kantarci K.
    J Neuroimaging; 2015 May 19; 25(2):269-274. PubMed ID: 25039916
    [Abstract] [Full Text] [Related]

  • 29. Correlation between hippocampal volumes and proton magnetic resonance spectroscopy of the posterior cingulate gyrus and hippocampi in Alzheimer's disease.
    Park EJ, Lyra KP, Lee HW, Caramelli P, Otaduy MCG, Leite CC.
    Dement Neuropsychol; 2010 May 19; 4(2):109-113. PubMed ID: 29213672
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of functional MRI markers in mild cognitive impairment.
    Zhang B, Li M, Sun ZZ, Zhu B, Yuan L, Wang Y, Xu Y.
    J Clin Neurosci; 2009 May 19; 16(5):635-41. PubMed ID: 19264490
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Longitudinal metabolic and cognitive changes in mild cognitive impairment patients.
    Olson BL, Holshouser BA, Britt W, Mueller C, Baqai W, Patra S, Petersen F, Kirsch WM.
    Alzheimer Dis Assoc Disord; 2008 May 19; 22(3):269-77. PubMed ID: 18580584
    [Abstract] [Full Text] [Related]

  • 34. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
    Almuqbel M, Melzer TR, Myall DJ, MacAskill MR, Pitcher TL, Livingston L, Wood KL, Keenan RJ, Dalrymple-Alford JC, Anderson TJ.
    Parkinsonism Relat Disord; 2016 Jan 19; 22():54-61. PubMed ID: 26627939
    [Abstract] [Full Text] [Related]

  • 35. Brain metabolism assessed via proton magnetic resonance spectroscopy in patients with amnestic or vascular mild cognitive impairment.
    Zhu X, Cao L, Hu X, Dong Y, Wang H, Liu F, Sun Z.
    Clin Neurol Neurosurg; 2015 Mar 19; 130():80-5. PubMed ID: 25590663
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Diffusion tensor imaging correlates with proton magnetic resonance spectroscopy in posterior cingulate region of patients with Alzheimer's disease.
    Ding B, Chen KM, Ling HW, Zhang H, Chai WM, Li X, Wang T.
    Dement Geriatr Cogn Disord; 2008 Mar 19; 25(3):218-25. PubMed ID: 18219201
    [Abstract] [Full Text] [Related]

  • 38. Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS.
    Kantarci K, Weigand SD, Przybelski SA, Shiung MM, Whitwell JL, Negash S, Knopman DS, Boeve BF, O'Brien PC, Petersen RC, Jack CR.
    Neurology; 2009 Apr 28; 72(17):1519-25. PubMed ID: 19398707
    [Abstract] [Full Text] [Related]

  • 39. N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI).
    Walecki J, Barcikowska M, Ćwikła JB, Gabryelewicz T.
    Med Sci Monit; 2011 Dec 28; 17(12):MT105-11. PubMed ID: 22129910
    [Abstract] [Full Text] [Related]

  • 40. Characteristic early changes of Glu and Cho in brain regions affected by different types of subjective cognitive decline and their clinical significance.
    Zeng Z, He J, Yao T.
    Medicine (Baltimore); 2023 Dec 08; 102(49):e36457. PubMed ID: 38065860
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.